Literature DB >> 7896004

Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes.

L Belardinelli1, J C Shryock, Y Song, D Wang, M Srinivas.   

Abstract

The purpose of this review is to examine the role of the extracellular A1-adenosine (Ado) receptor in modulating membrane potential and currents in cardiac cells. The cellular electrophysiological effects of adenosine are both cell type- and species-dependent. In supraventricular tissues (SA, AV node, and atrium) of all species studied, the "direct" cAMP-independent activation of the inwardly rectifying K+ current IKAdo seems to be the most important action of adenosine. This current is activated by both adenosine and acetylcholine and flows through K+ channels with unitary slope conductance of about 45 pS and an open time constant of 1.4 ms. The density of K(+)-ACh,Ado channels is much less in ventricular than in atrial myocytes, and thus adenosine has little or no effect on the ventricular action potential. In atrial myocytes adenosine has a small inhibitory effect on basal L-type calcium current (ICa,L), but no effect on T-type calcium current (ICa,T). In ventricular myocytes, adenosine does not inhibit ICa,L (except ferret), ICa,T, or the sodium inward current INa. Adenosine has recently been shown to activate IKATP in ventricular membrane patches, but the relevance of this finding remains to be defined. Irrespective of cell type and species, adenosine inhibits membrane currents that are stimulated by beta-adrenergic agonists and other agents known to stimulate the activity of the enzyme adenylyl cyclase. This indirect cAMP-dependent mechanism of action has been shown to be responsible for the inhibition by adenosine of isoproterenol-stimulated ICa,L, delayed rectifier K+ current (IK), chloride current (ICl), the transient inward current ITi, and the pacemaker current IF. The importance of the actions of adenosine on membrane currents in modulation of atrial, ventricular, sinoatrial, and atrioventricular nodal function are discussed. Likewise, the antiarrhythmic and proarrhythmic actions of adenosine are discussed and the clinical implications of these actions are noted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7896004     DOI: 10.1096/fasebj.9.5.7896004

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  69 in total

Review 1.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 2.  Neoceptors: reengineering GPCRs to recognize tailored ligands.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Bruce T Liang
Journal:  Trends Pharmacol Sci       Date:  2007-02-05       Impact factor: 14.819

3.  Adenosine and its receptors as therapeutic targets: An overview.

Authors:  Sakshi Sachdeva; Monika Gupta
Journal:  Saudi Pharm J       Date:  2012-06-23       Impact factor: 4.330

Review 4.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Authors:  S Jamal Mustafa; R Ray Morrison; Bunyen Teng; Amir Pelleg
Journal:  Handb Exp Pharmacol       Date:  2009

Review 5.  Regulation of neurite outgrowth by G(i/o) signaling pathways.

Authors:  Kenneth D Bromberg; Ravi Iyengar; John Cijiang He
Journal:  Front Biosci       Date:  2008-05-01

6.  Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A3 adenosine receptors in cardiomyoyctes.

Authors:  Tina C Wan; Akihito Tampo; Wai-Meng Kwok; John A Auchampach
Journal:  Biochem Pharmacol       Date:  2019-01-30       Impact factor: 5.858

7.  Enhanced adenosine A(2B) mediated coronary response in reserpinised rat heart.

Authors:  Roselyn B Rose'Meyer; Glenn J Harrison; John P Headrick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-14       Impact factor: 3.000

Review 8.  Mechanism, diagnosis, and treatment of outflow tract tachycardia.

Authors:  Bruce B Lerman
Journal:  Nat Rev Cardiol       Date:  2015-08-18       Impact factor: 32.419

9.  Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine.

Authors:  Jiang-Ning Yang; Jiang-Fan Chen; Bertil B Fredholm
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-13       Impact factor: 4.733

10.  Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo.

Authors:  Michael Koeppen; Tobias Eckle; Holger K Eltzschig
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.